Bruce Montgomery Joins Zymo Board

Luke Timmerman3/11/10

Bruce Montgomery, the senior vice president of Gilead Sciences in Seattle, is joining the board of directors at Seattle-based ZymoGenetics (NASDAQ: ZGEN). ZymoGenetics also said that Lars Rebien Sorensen, the CEO of Novo Nordisk, has resigned from the board. Montgomery recently led the team at Gilead that won FDA approval of a new inhalable antibiotic treatment for cystic fibrosis.

Luke Timmerman is the National Biotech Editor of Xconomy. E-mail him at ltimmerman@xconomy.com Follow @